March 1 (Reuters) - Sarepta Therapeutics Inc :
* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q4 NON-GAAP LOSS PER SHARE $1.84
* Q4 EARNINGS PER SHARE ESTIMATE $-1.87 -- REFINITIV IBES DATA
* NET PRODUCT SALES FOR Q4 OF $122.6 MILLION
* QTRLY TOTAL REVENUES $145.1 MILLION VERSUS $100.1 MILLION
* QTRLY LOSS PER SHARE $2.40
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q4 NON-GAAP LOSS PER SHARE $1.84
* Q4 EARNINGS PER SHARE ESTIMATE $-1.87 -- REFINITIV IBES DATA
* NET PRODUCT SALES FOR Q4 OF $122.6 MILLION
* QTRLY TOTAL REVENUES $145.1 MILLION VERSUS $100.1 MILLION
* QTRLY LOSS PER SHARE $2.40
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)